Table 1

Clinical characteristics of patients
Patient number
 Age (yr)
 Sex
 Height (cm)
 Type
 Severity
 Total IgE in serum (IU/ml)
 Specific IgE in serum
 Complication of allergic disease
 PC20-FEV1 (mg/ml)*
 Bronchodilator response (%)**
 Treatment






















BDP (μg/day)
 Theophylline (mg/day)
 Clenbuterol (μg/day)
 Carbocysteine (mg/day)
1
 54
 M
 161
 Int
 Moderate
 420
 -
 -
 2.5
 15.2
 800
 400
 40
 0
2
 72
 F
 147
 Ext
 Moderate
 642
 Mite, HD
 AR
 0.31
 31.5
 800
 400
 0
 0
3
 70
 M
 161
 Ext
 Mild
 312
 Mite, HD, Cedar
 -
 0.08
 20.2
 0
 600
 0
 0
4
 71
 F
 140
 Int
 Mild
 17
 -
 -
 1.25
 17.6
 800
 0
 0
 0
5
 83
 M
 154
 Ext
 Moderate
 345
 Mite, HD, Cedar
 -
 5
 17.1
 800
 400
 40
 1500
6
 71
 M
 165
 Ext
 Moderate
 146
 Mite, HD
 AR
 1.25
 15.6
 0
 0
 40
 0
7
 77
 F
 144
 Int
 Mild
 51
 -
 -
 0.31
 17.9
 0
 0
 0
 1500
8
 71
 M
 155
 Int
 Mild
 42
 -
 -
 2.5
 29.4
 800
 0
 0
 1500
9
 80
 M
 152
 Int
 Moderate
 66
 -
 -
 1.25
 39
 800
 0
 0
 0
10
 75
 M
 162
 Ext
 Mild
 143
 Candida
 -
 2.5
 14.1
 800
 0
 0
 0
11
 80
 F
 145
 Ext
 Mild
 3
 HD, Cedar
 -
 0.08
 37.1
 800
 0
 0
 0
12
 63
 F
 154
 Ext
 Moderate
 77
 Cedar
 AR
 1.25
 14.7
 800
 0
 0
 0
13
 77
 F
 142
 Int
 Mild
 105
 -
 -
 5
 17
 0
 400
 20
 0
14
 70
 M
 155
 Int
 Moderate
 82
 -
 -
 0.31
 15.4
 800
 0
 0
 1500
15
 70
 F
 151
 Ext
 Mild
 467
 Mite, HD
 -
 2.5
 20.4
 800
 400
 40
 0
16
 72
 F
 150
 Int
 Mild
 57
 -
 -
 5
 22.3
 600
 0
 0
 1500
17
 81
 M
 163
 Int
 Moderate
 64
 -
 -
 0.31
 33.4
 800
 600
 40
 1500
18
 71
 M
 150
 Int
 Moderate
 107
 -
 -
 5
 16.4
 800
 400
 40
 0
19
 80
 M
 160
 Int
 Mild
 87
 -
 -
 2.5
 29.5
 0
 400
 0
 0
20
 68
 M
 167
 Ext
 Mild
 264
 Cedar
 -
 5
 27
 0
 400
 40
 0
21
 80
 F
 152
 Int
 Mild
 54
 -
 -
 2.5
 17.3
 0
 400
 0
 0

Ext, extrinsic; Int. Intrinsic; HD, house dust; AR, allergic rhinitis; UR, urticaria; BDP, beclomethasone diproprionate inhalation.

* PC20-FEV1 shows concentration of inhaled methacholine causing a 20% fall in FEV1.

** Bronchodilator response means percent increase in forced expiratory volume in 1s (FEV1) from the baseline value after inhalation of 300 μg of salbutamol sulfate.

All patients used inhaled β2-agonists (salbutamol or procaterol) on demand.

Ishiura et al. Cough 2007 3:2   doi:10.1186/1745-9974-3-2